Treating insulin allergy with continuous subcutaneous insulin infusion (CSII).
Kerr
D
D
Richardson
T
T
D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004342:Drug Hypersensitivity / Q000150:complications*; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007328:Insulin / Q000009:adverse effects*; D007332:Insulin Infusion Systems; D008297:Male; D008875:Middle Aged; D012867:Skin / Q000276:immunology; D016896:Treatment Outcome
D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin